Microwells

Creating novel devices for cancer detection and monitoring

Early detection and monitoring is critical to mounting effective cancer treatments. The molecular differences that make cancer cells lethal when left unchecked also provide the clues for their detection, identification and visualization.

Outreach

The Koch Institute engages public audiences of all ages and backgrounds in current cancer research through a variety of public events, youth outreach programs, and online resources about new cancer solutions.

Koch Institute Image Awards

The annual Koch Institute Image Awards were established to recognize and publicly display these extraordinary visuals. Out of nearly 100 submissions, 10 inaugural winning images were selected by an expert panel to appear in the Galleries.

Koch Institute Public Galleries

Visitors to the Koch Institute Public Galleries can explore current cancer research projects, examine striking biomedical images, hear personal reflections on cancer and cancer research and investigate the historical, geographical and scientific contexts out of which the Koch Institute emerged.

People

In creating a new era for cancer research, the Koch Institute’s greatest assets are its people. Our world renowned faculty unites leadership in multiple fields of science and engineering with a commitment to truly interdisciplinary collaboration.

Robotic Arm

Swanson Biotechnology Center

These 14 shared biotechnology laboratories provide state-of-the-art tools and specialized expertise to Koch Institute researchers, while also bringing together scientists and engineers to foster interdisciplinary collaboration.

Research at the Koch Institute

The Koch Institute brings scientists and engineers together to solve the problems of cancer.  We have identified five areas of research that we believe are critical for rapid progress toward controlling cancer.

People

Inside the Lab: Paul Chang

Learn more about the Chang lab’s work to better understand a family of proteins called PARPs, and how blocking specific PARPs might be a promising target for cancer therapies. 

Research

5 4 3 2 1

Our research is conducted in five areas:

Cancer Immunology

Cancer Immunology

Engineering the immune system to fight cancer... more

Personalized Medicine

Personalized Medicine

Advancing personalized medicine through analysis of cancer pathways and drug resistance... more

Metastasis

Metastasis

Exploring the molecular and cellular basis of metastasis... more

Detection + Monitoring

Detection + Monitoring

Creating novel devices for cancer detection and monitoring... more

Nano-based Drugs

Nano-based Drugs

Developing nanotechnology-based cancer therapeutics... more

Support

With your support, we aim to improve the lives of cancer patients. Our expert cancer biologists and engineers work in tandem to tackle today's most challenging cancer problems and deliver solutions that lead to longer, healthier lives.

Your contributions can make a difference in the fight against cancer. We welcome your help to continue our progress.

News + Events

Flash Mob

Cancer Immunotherapy Gets Flashy

On April 25, the KI community wielded pom-poms, foam fingers, umbrellas, T-shirts, and whistles to hack the immune system to fight cancer. more...

Celebrating Anniversaries at the Koch Institute

June 1974…1964…1944…cancer research historians, time travelers, and fans of the number four thrilled at the convergence of special anniversaries occurring at MIT in June 2014. more...

Lees & Weinberg Tackle Unanswered Questions

Jacqueline Lees, associate director of the Koch Institute and professor of biology, and Robert Weinberg, Daniel K. Ludwig Professor for Cancer Research and director of the KI’s Ludwig Center for Molecular Oncology, each tackled a still-unanswered question about cancer biology in the July issue of Scientific American. more...

Nisarg Shah & Stephen Morton

Small Particles, Big Collaborations

Layer by layer, Hammond Lab trainees Stephen Morton and Nisarg Shah work individually and collaboratively to develop nanoparticles for hard-to-treat cancers. more...

Approach

Center of Cancer Nanotechnology Excellence

The MIT-Harvard Center for Cancer Nanotechnology Excellence is a collaborative effort among MIT, Harvard University, Harvard Medical School, Massachusetts General Hospital, and Brigham and Women's Hospital. more

Making Tumors Vulnerable

Watch this animation to learn how the Bhatia lab uses nanomaterials to make tumors more susceptible to treatment. more

Sensing Cancer

Watch this animation to see how a tiny, implantable sensor developed by the Cima lab could enable continuous monitoring of cancer. more

Stopping the Spread of Cancer

Watch this animation to learn about the Gertler lab's efforts to understand and fight the deadly process of metastasis. more

Engineering the Immune System

Watch this animation to learn how the Irvine lab uses nanomaterials-based "cell backpacks" to boost the immune response to cancer. more

Cutting off Cancer's Food Supply

Watch this animation to learn how the Vander Heiden lab is working to understand and target cancer metabolism. more

Bridge Project

The Bridge Project is a collaboration between the Koch Institute and the Dana-Farber/Harvard Cancer Center (DF/HCC), designed to bring bioengineering and clinical oncology together to solve today’s most challenging problems in cancer research and care.

with/in/sight Lecture Series

Join us for a series of evening programs that bring together diverse expert perspectives to discuss emerging cancer solutions.